Isofol Medical AB (publ)

Informe acción OM:ISOFOL

Capitalización de mercado: kr112.3m

Isofol Medical Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Petter Lindqvist

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directivaless than a year

Actualizaciones recientes de la dirección

Recent updates

An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued

May 18
An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued

Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation

Nov 09
Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation

Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?

May 12
Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?

Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)

Apr 08
Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)

Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment

Mar 03
Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment

We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully

Jan 10
We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully

CEO

Petter Lindqvist

less than a year

Permanencia

Mr. Petter Segelman Lindqvist serves as Chief Executive Officer of Isofol Medical AB (publ) since January 09, 2024. He is Chief Executive Officer of Hamlet BioPharma AB (publ) (formerly known as Hamlet Pha...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Petter Lindqvist
Chief Executive Officerless than a yearsin datossin datos
Magnus Hurst
Chief Financial Officerless than a yearsin datossin datos
Roger Tell
Chief Medical Officerless than a yearsin datos0.0031%
SEK 3.5k

0.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de ISOFOL no se considera experimentado ( 0.3 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Jan-Eric Österlund
Independent Chairmanless than a yearkr996.00k0.40%
SEK 444.8k
Sten Nilsson
Independent Directorless than a yearsin datossin datos
Lars Lind
Independent Directorless than a yearkr29.00ksin datos
Alain Herrera
Independent Directorless than a yearkr271.00ksin datos
Helena Taflin
Independent Directorless than a yearsin datossin datos

0.3yrs

Permanencia media

76.5yo

Promedio de edad

Junta con experiencia: La junta directiva de ISOFOL no se considera experimentada (0.3 años de permanencia promedio), lo que sugiere una nueva junta directiva.